GO
Loading...

Government Agencies

More

  • Fed survey finds US economy growing at moderate pace Wednesday, 15 Apr 2015 | 2:02 PM ET

    In its latest survey of business conditions around the country, the Fed said that eight of its 12 banking regions described the economy as growing at either a moderate or modest pace with two others— Atlanta and Kansas City— describing conditions as steady. The report said that a slowdown in the chemical industry had been reported by contacts in St. Louis and...

  • CONCORD, N.H.— Senate Majority Leader Mitch McConnell's call for governors to defy proposed federal rules to limit pollution has been met with mostly silence, but leaders in downwind New England states and drought-stricken areas in the West are pushing back. Maggie Hassan, also a Democrat, pointed to efforts there, including the Regional Greenhouse Gas...

  • NEW YORK, April 15- U.S. That has at the margin supported the Treasury market this morning, "said Dan Mulholland, head of Treasuries trading at Credit Agricole in New York. New York Federal Reserve data earlier showed that growth in manufacturing activity in New York state also unexpectedly contracted in April, weakening for a third straight month as the pace of new...

  • WASHINGTON— U.S. industrial production registered the biggest drop in almost six years last month, another sign that the economy got off to a stumbling start in 2015.. The Federal Reserve said Wednesday that industrial production— which includes factories, utilities and mines— slid 0.6 percent in March, the biggest drop since a 1.1 drop in May 2009.

  • Cycle Gear recalling some toys for excessive lead levels Wednesday, 15 Apr 2015 | 8:45 AM ET

    NEW YORK— Cycle Gear Inc. is recalling about 155 semi-truck and motorcycle toys because of excessive lead levels. The Consumer Product Safety Commission said that the levels are above the federal standard for lead content. The recall includes the plastic Wheelies semi-truck with six motorcycles, which was priced at $20.

  • Ex-Millstone contractor asks US to protect whistleblowers Wednesday, 15 Apr 2015 | 6:14 AM ET

    WATERFORD, Conn.— A contractor who said he was fired from Millstone Power Station after he reported a co-worker abusing narcotics in 2011 has asked the Nuclear Regulatory Commission to protect whistleblowers at the nuclear plant. Stephen Lavoie, an insulation contractor, raised the issue Tuesday at the NRC's annual meeting with the Nuclear Energy Advisory...

  • DIARY- Top Economic Events to April 24 Tuesday, 14 Apr 2015 | 8:01 PM ET

    WASHINGTON- Federal Reserve issues the Beige Book of economic condition- 1800 GMT. WASHINGTON- Levy Economics Institute of Bard College holds 24th Annual Hyman P. Minsky Conference on the State of the U.S. and World Economies in Washington. WASHINGTON- Federal Reserve Bank of St. Louis President James Bullard gives presentation on the U.S. economy and monetary...

  • WINONA, Minn., April 14- Raising interest rates this year, as most Federal Reserve officials expect, would be "inappropriate" because it would delay the return of too-low inflation to the U.S. central bank's 2 percent goal, a top Fed official said on Tuesday. A rate hike would also work against the Fed's other goal of full employment, Narayana Kocherlakota, president of...

  • NEW YORK, April 14- AT&T Inc and three cable and wireless trade groups filed separate lawsuits on Tuesday challenging the U.S. Federal Communications Commission over its new web traffic regulations. The suit comes even as the No.2 U.S wireless company's proposed $48.5 billion acquisition of satellite TV operator DirecTV is under FCC review.

  • WASHINGTON, April 14- AstraZeneca Plc's diabetes drug Onglyza and Takeda Pharmaceutical Co.' s rival product Nesina should carry information about the risk of heart failure, an advisory committee to the U.S. Food and Drug Administration said on Tuesday. The panel reviewed safety data on AstraZeneca's Onglyza and Takeda's Nesina. The studies were requested by...

  • April 14- An advisory panel to the U.S. Food and Drug Administration voted 13-3 that Takeda Pharmaceutical's diabetes drug Nesina should contain information about a potential increased risk of heart failure. The panel voted 16-0 that the drug has an acceptable overall cardiovascular safety profile, with no significant increased risk of major heart events...

  • The FDA issued the guidelines to help clarify what changes require regulatory approval under the 2009 Tobacco Control Act. The guidelines go far beyond that authority, the plaintiffs said, by requiring FDA authorization to make any labeling changes that would render a product already on the market "distinct," like a name change. Although the FDA has framed the...

  • The FDA gained authority to regulate tobacco in 2009, including the power to pre-review new tobacco products that are significantly different from older ones already on the market. Last month the agency issued guidelines intended to help manufacturers determine which new products require FDA review. But the tobacco makers allege that the FDA is asserting...

  • A preliminary FDA review of Nesina, or alogliptin, showed a numerical increase in heart failure hospitalizations but not a statistically significant increase. Even so, some analysts expect the FDA to treat all drugs in the class the same way. "We believe the FDA will likely view the risk as likely to be a class effect and apply changes to all approved drugs in the...

  • Business events scheduled for Wednesday Tuesday, 14 Apr 2015 | 1:28 PM ET

    WASHINGTON— Federal Reserve releases Beige Book, 2 p.m.. WASHINGTON— National Association of Home Builders releases housing market index for April, 10 a.m.. WASHINGTON— Federal Reserve releases Beige Book, 2 p.m.; Treasury releases international money flows data for February, 4 p.m..

  • WASHINGTON, April 14- AstraZeneca Plc's diabetes drug Onglyza should include new safety information about the risk of heart failure, a U.S. Food and Drug Administration advisory panel concluded on Tuesday. The FDA is not obliged to follow the advice of its advisory panels but typically does so. A preliminary FDA review of the drug published on Friday noted an...

  • WASHINGTON, April 14- AstraZeneca Plc's diabetes drug Onglyza should include new safety information about the risk of heart failure, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday. The panel voted overwhelmingly that the drug's label should be changed to add information about an increased heart failure risk, but did not...

  • WASHINGTON, April 14- U.S. producer prices rose in March after four straight months of declines and there were signs of some firming in underlying inflation, which should keep the Federal Reserve on course to start raising interest rates this year. The Labor Department said on Tuesday its producer price index for final demand increased 0.2 percent last month,...

  • DIARY- Top Economic Events to April 23 Monday, 13 Apr 2015 | 8:01 PM ET

    STOCKHOLM- Sweden's Riksbank Deputy Governor Cecilia Skingsley will participate in a seminar on pay formation that promotes the competitiveness of the manufacturing industry- 1135 GMT. WASHINGTON- Federal Reserve issues the Beige Book of economic condition- 1800 GMT. WASHINGTON- Levy Economics Institute of Bard College holds 24th Annual Hyman P. Minsky...

  • The products are sold online and by some retailers and gyms, the FDA said in a statement Monday. The FDA says consumers who have taken the supplements should watch out for potential signs of adverse effects, including unexplained fatigue, abdominal or back pain or discolored urine. Charles Lee, a senior scientist with the FDA, in a statement.